Skip to main content
Figure 2 | BMC Endocrine Disorders

Figure 2

From: Clinical characteristics and beta cell function in Chinese patients with newly diagnosed type 2 diabetes mellitus with different levels of serum triglyceride

Figure 2

Ī² cell function and insulin sensitivity. (a): Log HOMA-Ī² (homeostasis model assessment of Ī² cell function) level in patients of newly diagnosed type 2 diabetes mellitus (T2DM) with different level of triglyceride (TG); (b): Log modified beta cell function index (MBCI) level in patients of newly diagnosed T2DM with different level of TG; (c): Glucose disposition indices (DI) level in patients of newly diagnosed T2DM with different level of TG; (d): Early insulin secretion function index (IGI) level in patients of newly diagnosed T2DM with different level of TG; (e): Log HOMA-IR (homeostasis model assessment of insulin resistance) level in patients of newly diagnosed T2DM with different level of TG; (f): Insulin action index (IAI) level in patients of newly diagnosed T2DM with different level of TG. Group was defined by the quartile of serum TG. Group 1: newly diagnosed T2DM with TG up to 1.13Ā mmol/L; Group 2: newly diagnosed T2DM with TG of 1.14 to 1.56Ā mmol/L; Group 3: newly diagnosed T2DM with TG of 1.57 to 2.27Ā mmol/L; and Group 4: newly diagnosed T2DM with TG of 2.28 to 11.65Ā mmol/L. *Pā€‰<ā€‰0.05 versus Group 1; #Pā€‰<ā€‰0.05 versus Group 2; +Pā€‰<ā€‰0.05 versus Group.

Back to article page